242 related articles for article (PubMed ID: 30476134)
1. Role of MIC levels of resistance to clarithromycin and metronidazole in Helicobacter pylori eradication.
De Francesco V; Zullo A; Fiorini G; Saracino IM; Pavoni M; Vaira D
J Antimicrob Chemother; 2019 Mar; 74(3):772-774. PubMed ID: 30476134
[TBL] [Abstract][Full Text] [Related]
2. Nonbismuth quadruple (concomitant) therapy: empirical and tailored efficacy versus standard triple therapy for clarithromycin-susceptible Helicobacter pylori and versus sequential therapy for clarithromycin-resistant strains.
Molina-Infante J; Pazos-Pacheco C; Vinagre-Rodriguez G; Perez-Gallardo B; Dueñas-Sadornil C; Hernandez-Alonso M; Gonzalez-Garcia G; Mateos-Rodriguez JM; Fernandez-Bermejo M; Gisbert JP
Helicobacter; 2012 Aug; 17(4):269-76. PubMed ID: 22759326
[TBL] [Abstract][Full Text] [Related]
3. The relationship between consumption of antimicrobial agents and the prevalence of primary Helicobacter pylori resistance.
Perez Aldana L; Kato M; Nakagawa S; Kawarasaki M; Nagasako T; Mizushima T; Oda H; Kodaira J; Shimizu Y; Komatsu Y; Zheng R; Takeda H; Sugiyama T; Asaka M
Helicobacter; 2002 Oct; 7(5):306-9. PubMed ID: 12390210
[TBL] [Abstract][Full Text] [Related]
4. High prevalence of Helicobacter pylori infection with dual resistance to metronidazole and clarithromycin in Hong Kong.
Wang WH; Wong BC; Mukhopadhyay AK; Berg DE; Cho CH; Lai KC; Hu WH; Fung FM; Hui WM; Lam SK
Aliment Pharmacol Ther; 2000 Jul; 14(7):901-10. PubMed ID: 10886046
[TBL] [Abstract][Full Text] [Related]
5. [Changing patterns of antibiotic resistance of Helicobacter pylori in patients with peptic ulcer disease].
Bang SY; Han DS; Eun CS; Kim JE; Ahn SB; Sohn JH; Jeon YC; Kang JO
Korean J Gastroenterol; 2007 Dec; 50(6):356-62. PubMed ID: 18159172
[TBL] [Abstract][Full Text] [Related]
6. The importance of the level of metronidazole resistance for the success of Helicobacter pylori eradication.
Wheeldon TU; Granström M; Hoang TT; Phuncarg DC; Nilsson LE; Sörberg M
Aliment Pharmacol Ther; 2004 Jun; 19(12):1315-21. PubMed ID: 15191514
[TBL] [Abstract][Full Text] [Related]
7. Helicobacter pylori eradication therapy outcome according to clarithromycin susceptibility testing in Japan.
Horie R; Handa O; Ando T; Ose T; Murakami T; Suzuki N; Sendo R; Imamoto E; Itoh Y
Helicobacter; 2020 Aug; 25(4):e12698. PubMed ID: 32368846
[TBL] [Abstract][Full Text] [Related]
8. High Helicobacter pylori resistance to metronidazole and clarithromycin in Brazilian children and adolescents.
Ogata SK; Godoy AP; da Silva Patricio FR; Kawakami E
J Pediatr Gastroenterol Nutr; 2013 Jun; 56(6):645-8. PubMed ID: 23403439
[TBL] [Abstract][Full Text] [Related]
9. [Acquisition of secondary resistance after failure of a first treatment of Helicobacter pylori infection in children].
Kalach N; Benhamou PH; Bergeret M; Gottrand F; Husson MO; Barbier C; Dupont C; Raymond J
Arch Pediatr; 2002 Feb; 9(2):130-5. PubMed ID: 11915493
[TBL] [Abstract][Full Text] [Related]
10. The impact of antibiotic resistance on the efficacy of three 7-day regimens against Helicobacter pylori.
Savarino V; Zentilin P; Pivari M; Bisso G; Raffaella Mele M; Bilardi C; Borro P; Dulbecco P; Tessieri L; Mansi C; Borgonovo G; De Salvo L; Vigneri S
Aliment Pharmacol Ther; 2000 Jul; 14(7):893-900. PubMed ID: 10886045
[TBL] [Abstract][Full Text] [Related]
11. Clinical evaluation of a ten-day regimen with esomeprazole, metronidazole, amoxicillin, and clarithromycin for the eradication of Helicobacter pylori in a high clarithromycin resistance area.
Georgopoulos SD; Xirouchakis E; Martinez-Gonzalez B; Sgouras DN; Spiliadi C; Mentis AF; Laoudi F
Helicobacter; 2013 Dec; 18(6):459-67. PubMed ID: 23714140
[TBL] [Abstract][Full Text] [Related]
12. Culture-based selection therapy for patients who did not respond to previous treatment for Helicobacter pylori infection.
Fiorini G; Vakil N; Zullo A; Saracino IM; Castelli V; Ricci C; Zaccaro C; Gatta L; Vaira D
Clin Gastroenterol Hepatol; 2013 May; 11(5):507-10. PubMed ID: 23267869
[TBL] [Abstract][Full Text] [Related]
13. Five-year sequential changes in secondary antibiotic resistance of Helicobacter pylori in Taiwan.
Wu IT; Chuah SK; Lee CH; Liang CM; Lu LS; Kuo YH; Yen YH; Hu ML; Chou YP; Yang SC; Kuo CM; Kuo CH; Chien CC; Chiang YS; Chiou SS; Hu TH; Tai WC
World J Gastroenterol; 2015 Oct; 21(37):10669-74. PubMed ID: 26457027
[TBL] [Abstract][Full Text] [Related]
14. A 9 year study of clarithromycin and metronidazole resistance in Helicobacter pylori from Spanish children.
López-Brea M; Martínez MJ; Domingo D; Alarcón T
J Antimicrob Chemother; 2001 Aug; 48(2):295-7. PubMed ID: 11481305
[TBL] [Abstract][Full Text] [Related]
15. Clarithromycin-Based Triple Therapy is Still Useful as an Initial Treatment for
Miftahussurur M; Cruz M; Subsomwong P; Jiménez Abreu JA; Hosking C; Nagashima H; Akada J; Yamaoka Y
Am J Trop Med Hyg; 2017 May; 96(5):1050-1059. PubMed ID: 28193745
[TBL] [Abstract][Full Text] [Related]
16. Helicobacter pylori treatment and antibiotic susceptibility: results of a five-year audit.
Fraser AG; Moore L; Hackett M; Hollis B
Aust N Z J Med; 1999 Aug; 29(4):512-6. PubMed ID: 10868529
[TBL] [Abstract][Full Text] [Related]
17. Comparison of the Etest and the NCCLS-approved agar dilution method to detect metronidazole and clarithromycin resistant Helicobacter pylori.
Osato MS; Reddy R; Reddy SG; Penland RL; Graham DY
Int J Antimicrob Agents; 2001 Jan; 17(1):39-44. PubMed ID: 11137647
[TBL] [Abstract][Full Text] [Related]
18. Antibiotic susceptibility of Helicobacter pylori in Iceland.
Gunnarsdottir AI; Gudjonsson H; Hardardottir H; Jonsdottir KD; Bjornsson ES
Infect Dis (Lond); 2017 Sep; 49(9):647-654. PubMed ID: 28440099
[TBL] [Abstract][Full Text] [Related]
19. Incidence of secondary Helicobacter pylori resistance to antibiotics in treatment failures after 1-week proton pump inhibitor-based triple therapies: a prospective study.
Pilotto A; Franceschi M; Rassu M; Leandro G; Bozzola L; Furlan F; Di Mario F
Dig Liver Dis; 2000 Nov; 32(8):667-72. PubMed ID: 11142574
[TBL] [Abstract][Full Text] [Related]
20. Emerging Helicobacter pylori levofloxacin resistance and novel genetic mutation in Nepal.
Miftahussurur M; Shrestha PK; Subsomwong P; Sharma RP; Yamaoka Y
BMC Microbiol; 2016 Nov; 16(1):256. PubMed ID: 27809767
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
